ZA200304809B - Process for the synthesis of a peptide having a tryptophan residue. - Google Patents
Process for the synthesis of a peptide having a tryptophan residue. Download PDFInfo
- Publication number
- ZA200304809B ZA200304809B ZA200304809A ZA200304809A ZA200304809B ZA 200304809 B ZA200304809 B ZA 200304809B ZA 200304809 A ZA200304809 A ZA 200304809A ZA 200304809 A ZA200304809 A ZA 200304809A ZA 200304809 B ZA200304809 B ZA 200304809B
- Authority
- ZA
- South Africa
- Prior art keywords
- boc
- trp
- resin
- peptide
- pro
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 62
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 30
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 title claims description 7
- 230000015572 biosynthetic process Effects 0.000 title description 11
- 238000003786 synthesis reaction Methods 0.000 title description 11
- 229920005989 resin Polymers 0.000 claims description 47
- 239000011347 resin Substances 0.000 claims description 47
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 34
- -1 organic acid salt Chemical class 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 17
- 229940024606 amino acid Drugs 0.000 claims description 16
- 229910021529 ammonia Inorganic materials 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 125000006239 protecting group Chemical group 0.000 claims description 14
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 8
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims description 8
- NQIHMZLGCZNZBN-PXNSSMCTSA-N Trp-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)N)C(O)=O)=CNC2=C1 NQIHMZLGCZNZBN-PXNSSMCTSA-N 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 7
- 150000003141 primary amines Chemical class 0.000 claims description 7
- 150000003335 secondary amines Chemical class 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000010532 solid phase synthesis reaction Methods 0.000 claims description 6
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 4
- 125000003941 D-tryptophan group Chemical group [H]C1=C([H])C([H])=C2C(C([C@@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 claims description 4
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000007822 coupling agent Substances 0.000 claims description 4
- 238000005897 peptide coupling reaction Methods 0.000 claims description 4
- 239000003880 polar aprotic solvent Substances 0.000 claims description 4
- 239000012047 saturated solution Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 claims description 3
- 210000004899 c-terminal region Anatomy 0.000 claims description 3
- 238000003776 cleavage reaction Methods 0.000 claims description 3
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 claims description 3
- 230000007017 scission Effects 0.000 claims description 3
- AYMLQYFMYHISQO-QMMMGPOBSA-N (2s)-3-(1h-imidazol-3-ium-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CN=CN1 AYMLQYFMYHISQO-QMMMGPOBSA-N 0.000 claims description 2
- WXYGVKADAIJGHB-ZDUSSCGKSA-N (2s)-3-(1h-indol-2-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound C1=CC=C2NC(C[C@H](NC(=O)OC(C)(C)C)C(O)=O)=CC2=C1 WXYGVKADAIJGHB-ZDUSSCGKSA-N 0.000 claims description 2
- CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 claims description 2
- FHOAKXBXYSJBGX-YFKPBYRVSA-N (2s)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)C(O)=O FHOAKXBXYSJBGX-YFKPBYRVSA-N 0.000 claims description 2
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims description 2
- MDXGYYOJGPFFJL-QMMMGPOBSA-N N(alpha)-t-butoxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OC(C)(C)C MDXGYYOJGPFFJL-QMMMGPOBSA-N 0.000 claims description 2
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 claims description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 230000005587 bubbling Effects 0.000 claims description 2
- 150000004702 methyl esters Chemical class 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 2
- 229920005990 polystyrene resin Polymers 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 108700012941 GNRH1 Proteins 0.000 description 10
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010647 peptide synthesis reaction Methods 0.000 description 3
- HBAHZZVIEFRTEY-UHFFFAOYSA-N 2-heptylcyclohex-2-en-1-one Chemical compound CCCCCCCC1=CCCCC1=O HBAHZZVIEFRTEY-UHFFFAOYSA-N 0.000 description 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- 229920001367 Merrifield resin Polymers 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical class [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CNMAQBJBWQQZFZ-LURJTMIESA-N (2s)-2-(pyridin-2-ylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC1=CC=CC=N1 CNMAQBJBWQQZFZ-LURJTMIESA-N 0.000 description 1
- HOBACDWMUXDSHY-QMMMGPOBSA-N (2s)-2-(quinolin-2-ylamino)propanoic acid Chemical compound C1=CC=CC2=NC(N[C@@H](C)C(O)=O)=CC=C21 HOBACDWMUXDSHY-QMMMGPOBSA-N 0.000 description 1
- LKENCKKEVBCYAE-VIFPVBQESA-N (2s)-2-[butyl-(diaminomethylideneamino)amino]-6-(diaminomethylideneamino)hexanoic acid Chemical compound CCCCN(NC(N)=N)[C@H](C(O)=O)CCCCNC(N)=N LKENCKKEVBCYAE-VIFPVBQESA-N 0.000 description 1
- LAKPFBJORILZSA-ILDUYXDCSA-N (2s)-2-amino-3-[4-(pyrazine-2-carbonylamino)cyclohexyl]propanoic acid Chemical compound C1CC(C[C@H](N)C(O)=O)CCC1NC(=O)C1=CN=CC=N1 LAKPFBJORILZSA-ILDUYXDCSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- NIGWMJHCCYYCSF-QMMMGPOBSA-N 4-chloro-L-phenylalanine Chemical group OC(=O)[C@@H](N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-QMMMGPOBSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- 101001090725 Leuconostoc gelidum Bacteriocin leucocin-A Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 208000006155 precocious puberty Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- JPZXHKDZASGCLU-LBPRGKRZSA-N β-(2-naphthyl)-alanine Chemical compound C1=CC=CC2=CC(C[C@H](N)C(O)=O)=CC=C21 JPZXHKDZASGCLU-LBPRGKRZSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/068—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for heterocyclic side chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE20001079 | 2000-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200304809B true ZA200304809B (en) | 2004-04-20 |
Family
ID=11042704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200304809A ZA200304809B (en) | 2000-12-22 | 2003-06-20 | Process for the synthesis of a peptide having a tryptophan residue. |
Country Status (25)
Country | Link |
---|---|
US (1) | US7122628B2 (cs) |
EP (1) | EP1343808B1 (cs) |
JP (1) | JP4064817B2 (cs) |
KR (1) | KR100591832B1 (cs) |
CN (2) | CN1481389A (cs) |
AT (1) | ATE339442T1 (cs) |
AU (1) | AU2002222439C1 (cs) |
BR (1) | BR0116447B1 (cs) |
CA (1) | CA2432708C (cs) |
CZ (1) | CZ299141B6 (cs) |
DE (1) | DE60123115T2 (cs) |
DK (1) | DK1343808T3 (cs) |
ES (1) | ES2266104T3 (cs) |
HK (1) | HK1055749A1 (cs) |
HU (2) | HU229701B1 (cs) |
IE (1) | IES20011090A2 (cs) |
IL (2) | IL156258A0 (cs) |
MX (1) | MXPA03005678A (cs) |
NO (1) | NO325038B1 (cs) |
NZ (1) | NZ526990A (cs) |
PL (1) | PL205949B1 (cs) |
PT (1) | PT1343808E (cs) |
RU (1) | RU2276156C2 (cs) |
WO (1) | WO2002051861A2 (cs) |
ZA (1) | ZA200304809B (cs) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091311B2 (en) | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
DK1542714T3 (da) | 2002-09-18 | 2014-05-26 | Janssen Pharmaceuticals Inc | Fremgangsmåder til forøgelse af produktion af blodplader og hæmatopoietiske stamceller |
CN102241742B (zh) * | 2003-08-28 | 2014-04-02 | 奥索-麦克尼尔药品公司 | 结合血小板生成素受体的肽和化合物 |
EP1968995A1 (en) * | 2005-12-30 | 2008-09-17 | F. Hoffmann-la Roche AG | Methods for the synthesis of arginine-containing peptides |
CN103517915B (zh) * | 2012-09-27 | 2015-11-25 | 深圳翰宇药业股份有限公司 | 一种制备布舍瑞林的方法 |
US10308677B2 (en) | 2014-12-19 | 2019-06-04 | Cem Corporation | Coupling method for peptide synthesis at elevated temperatures |
US9969769B2 (en) | 2014-12-19 | 2018-05-15 | Cem Corporation | Coupling method for peptide synthesis at elevated temperatures |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211693A (en) * | 1977-09-20 | 1980-07-08 | The Salk Institute For Biological Studies | Peptides with para-substituted phenylalanine |
US4569927A (en) * | 1984-02-23 | 1986-02-11 | The Salk Institute For Biological Studies | GnRH Antagonists IV |
IL74827A (en) | 1984-05-21 | 1989-06-30 | Salk Inst For Biological Studi | Peptides active as gnrh antagonists and pharmaceutical compositions containing them |
IT1203600B (it) | 1985-12-06 | 1989-02-15 | Phidea Srl | Metodo per preparare il (d-trp6)-lhrh |
US5175254A (en) * | 1988-09-24 | 1992-12-29 | Societe D'expansion Scientifque Expansia | Solid phase peptide synthesis using a polyacrylic support in aqueous solution |
GB8822502D0 (en) | 1988-09-24 | 1988-10-26 | Expansia Sa | New peptide synthesis method |
JPH05331188A (ja) | 1992-05-28 | 1993-12-14 | Nippon Chemiphar Co Ltd | トリペプチド、その製造方法及びエンドセリン拮抗剤 |
-
2001
- 2001-12-19 PL PL361993A patent/PL205949B1/pl unknown
- 2001-12-19 HU HU0302633A patent/HU229701B1/hu unknown
- 2001-12-19 US US10/451,486 patent/US7122628B2/en not_active Expired - Lifetime
- 2001-12-19 CN CNA018210384A patent/CN1481389A/zh active Pending
- 2001-12-19 BR BRPI0116447-3B1A patent/BR0116447B1/pt active IP Right Grant
- 2001-12-19 IL IL15625801A patent/IL156258A0/xx active IP Right Grant
- 2001-12-19 HU HU1400157A patent/HU230601B1/hu unknown
- 2001-12-19 PT PT01272223T patent/PT1343808E/pt unknown
- 2001-12-19 ES ES01272223T patent/ES2266104T3/es not_active Expired - Lifetime
- 2001-12-19 DK DK01272223T patent/DK1343808T3/da active
- 2001-12-19 CA CA2432708A patent/CA2432708C/en not_active Expired - Lifetime
- 2001-12-19 CZ CZ20031634A patent/CZ299141B6/cs not_active IP Right Cessation
- 2001-12-19 DE DE60123115T patent/DE60123115T2/de not_active Expired - Lifetime
- 2001-12-19 MX MXPA03005678A patent/MXPA03005678A/es active IP Right Grant
- 2001-12-19 CN CNA2007100047879A patent/CN101003563A/zh active Pending
- 2001-12-19 JP JP2002552954A patent/JP4064817B2/ja not_active Expired - Lifetime
- 2001-12-19 EP EP01272223A patent/EP1343808B1/en not_active Expired - Lifetime
- 2001-12-19 NZ NZ526990A patent/NZ526990A/xx not_active IP Right Cessation
- 2001-12-19 RU RU2003122779/04A patent/RU2276156C2/ru not_active IP Right Cessation
- 2001-12-19 AT AT01272223T patent/ATE339442T1/de active
- 2001-12-19 KR KR1020037008232A patent/KR100591832B1/ko active IP Right Grant
- 2001-12-19 WO PCT/IE2001/000159 patent/WO2002051861A2/en active IP Right Grant
- 2001-12-19 AU AU2002222439A patent/AU2002222439C1/en not_active Expired
- 2001-12-20 IE IE20011090A patent/IES20011090A2/en not_active IP Right Cessation
-
2003
- 2003-06-02 IL IL156258A patent/IL156258A/en unknown
- 2003-06-20 NO NO20032852A patent/NO325038B1/no not_active IP Right Cessation
- 2003-06-20 ZA ZA200304809A patent/ZA200304809B/en unknown
- 2003-11-04 HK HK03107934A patent/HK1055749A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7348404B2 (en) | Solid-phase peptide synthesis and agent for use in such synthesis | |
CA1248700A (en) | Gnrh agonists | |
IE882185L (en) | Lhrh antagonists | |
Bajusz et al. | Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6. | |
ZA200107753B (en) | Novel LHRH antagonists with improved solubility characteristics. | |
US7122628B2 (en) | Process for the synthesis of a peptide having a Trp residue | |
AU2002222439A1 (en) | Process for the synthesis of a peptide having a tryptophan residue | |
US5212288A (en) | Temporary minimal protection synthesis of serine-containing polypeptides | |
US7176282B1 (en) | Solid-phase peptide synthesis and agent for use in such synthesis | |
Grandas et al. | Convergent solid phase peptide synthesis. VII. Good yields in the coupling of protected segments on a solid support | |
US5432263A (en) | Process for producing peptides with side chains containing imidazolinylamino, tetrahydropyrimidinylamino, or alkylguanidinyl groups | |
CA1335403C (en) | Process and intermediates for lh-rh peptides | |
AU2005202990A1 (en) | Process for the synthesis of a peptide having a tryptophan residue | |
FI102538B (fi) | LH-RH-analogien synteesi väliaikaisella, pienimmällä mahdollisella suo jauksella | |
EP0056274A1 (en) | Indole derivatives and a method for production of peptides | |
RU2043362C1 (ru) | Способ твердофазного синтеза пептидов | |
FI101884B (fi) | Luteinisoivaa hormonia vapauttavan hormonin (LHRH) antagonistipeptidej ä | |
Borin et al. | Studies on cytochrome c. Part IV. Synthesis of the protected dodecapeptide (sequence 45–56) of Baker's yeast iso‐1‐cytochrome c | |
IL97216A (en) | Temporary minimal protection in solid phase synthesis of LH HR analogues |